Ong Yee Lung - 05 Nov 2025 Form 4 Insider Report for Bio Green Med Solution, Inc. (CYCC)

Reporting relationship: 10%+ Owner
Issuer ticker: CYCC
Reported as of: 05 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Nov 2025, 18:00:03 UTC
Prior SEC filing: 03 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Ong Yee Lung

Key filing fact

Ong Yee Lung filed Form 4 for Bio Green Med Solution, Inc. (CYCC) on 05 Nov 2025.

Key facts

This page summarizes Ong Yee Lung's Form 4 filing for Bio Green Med Solution, Inc. (CYCC).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 05 Nov 2025, 18:00.

Change

Previous filing in this sequence was filed on 03 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002081473 Primary reporting owner

Ong Yee Lung

Relationship: 10%+ Owner
Address: 9 JALAN LAWA 3 TAMAN PELANGI, INDAH ULU TIRAM, JOHOR BAHRU, MALAYSIA
Signature: /s/ Ong Yee Lung
Signature date: 05 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BGMS transaction

Common Stock

Other

Transaction value: $0
Shares: +467,535
Change %
Price: $0.000000
Shares after: 467,535
Date: 05 Nov 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BGMS transaction Derivative

Series A Common Stock Warrants

Other

Transaction value: $0
Shares: -218,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 218,000
Exercise price: $7.65
Footnotes: F1

BGMS transaction Derivative

Series B Common Stock Warrants

Other

Transaction value: $0
Shares: -218,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 218,000
Exercise price: $9.00
Footnotes: F1

BGMS transaction Derivative

Series C Common Stock Warrants

Other

Transaction value: $0
Shares: -31,535
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 31,535
Exercise price: $10.20
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Ong Yee Lung is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025